INO has a very long, hard road to seeing any real pps growth. Their vaccines and all their advancements have years before coming to fruition. Seeing the stock do well presently is nothing more than investor hype and hope. It has zero legs to maintain its current run and IT WILL fall again soon and retrace. For all of those who bought into this hype-hope base run may u be so lucky for INO not to fall too far. This is reality of a penny stock. It happens ALL the time and it will be no different with INO.
Well, let's see what the hep c phase 2 data show...that will be followed by more data from other vaccine trials throughout the year...and, then early 2014 malaria trial will be conducted, with vaccinations followed shortly by challenge with the actual malarial parasite...that doesn't sound like a company whose fortunes are all that far off when you think seriously about it...I don't think you have a clue regarding the science behind this company's vaccine pipeline and electroporation technology...not really sure why you are on this board, other to obfuscate the stellar results up to this point of INO...GLTALongs!$
Like most of the investors of INO understand the science of their vaccines LOL. It's a very speculative stock because at any phase of testing their vaccines/science could fail to work as intended and then this thing is dead in the water. That's how these bio stocks play out. Be careful that's my point. Your over zealous attitude may get you burned badly.